Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
The human stomach is an incredibly acidic environment, with a pH that can drop as low as 1.5
Where should they look
This allows for more immediate systemic availability and the possibility of localized administration near an injury site
Triple-hormone-receptor agonist Retatrutide for obesity: Phase 2 trial (48-week study, up to 24% weight loss) American Diabetes Association (2023) ADA Press Release: Novel agent Retatrutide results in substantial weight reduction (83rd Scientific Sessions, Phase 2 data) ADA Meeting News (2023) Phase 2 trial results: benefits of Retatrutide in obesity, type 2 diabetes, NASH (83rd ADA Scientific Sessions coverage) ClinicalTrials.gov Study of Retatrutide (LY3437943) in adults with obesity (NCT04881760
Once reconstituted, store in the refrigerator and use within a short period to maintain integrity
